IART
INTEGRA LIFESCIENCES HOLDINGS CORPCompany Information
- Company Name
- INTEGRA LIFESCIENCES HOLDINGS CORP
- CIK
- CIK0000917520
- Category
- Large accelerated filer
- Ticker: Exchange
- IART: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- IART
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-11-05
- Last sale
- 2024-12-03
- Shares purchased (TTM)
- 9,000
- Shares sold (TTM)
- 5,770
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 73,853,617
- Shares outstanding
- 77,293,000
- Ownership
- 95.55%
Earnings Market Reaction
- Filing date
- 2026-07-29
- Price on filing date
- —
- 1-month reaction
- 1.52%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 214 | 237 | 235 | 232 | 218 | 239 | 246 | 215 | 215 | 592 | 276 | 274 | ||||||
| Short Term Investments | 60 | 29 | 29 | 36 | 36 | 34 | 27 | 62 | 82 | 71 | 33 | - | ||||||
| Accounts Receivable Net Current | 267 | 264 | 279 | 262 | 285 | 252 | 272 | 248 | 271 | 241 | 259 | 256 | ||||||
| Inventory Net | 492 | 495 | 493 | 489 | 465 | 445 | 429 | 437 | 422 | 403 | 390 | 366 | ||||||
| Prepaid Expense And Other Assets Current | - | - | - | - | - | - | - | - | - | - | - | 131 | ||||||
| Prepaid Expense Current | 104 | 98 | 96 | 94 | 103 | 104 | 77 | 86 | 94 | 73 | 67 | - | ||||||
| Other Assets Current | 54 | 49 | 28 | 30 | 36 | 32 | 30 | 50 | 29 | 35 | 33 | - | ||||||
| Assets Current | 1,191 | 1,172 | 1,160 | 1,144 | 1,143 | 1,107 | 1,082 | 1,100 | 1,112 | 1,416 | 1,058 | 1,027 | ||||||
| Property Plant And Equipment Net | 446 | 447 | 444 | 437 | 435 | 423 | 406 | 391 | 374 | 345 | 340 | 319 | ||||||
| Operating Lease Right Of Use Asset | 137 | 137 | 141 | 138 | 137 | 138 | 144 | 146 | 147 | 152 | 156 | 157 | ||||||
| Intangible Assets Net Excluding Goodwill | 1,076 | 1,105 | 1,135 | 1,160 | 1,188 | 1,188 | 1,208 | 1,210 | 1,220 | 1,023 | 1,068 | 1,067 | ||||||
| Goodwill | 611 | 613 | 615 | 615 | 616 | 1,105 | 1,097 | 1,117 | 1,105 | 1,040 | 1,055 | 1,036 | ||||||
| Deferred Income Tax Assets Net | 70 | 68 | 70 | 110 | 103 | 38 | 35 | 49 | 46 | 34 | 46 | 56 | ||||||
| Other Assets Noncurrent | 32 | 35 | 38 | 42 | 46 | 53 | 67 | 54 | 71 | 68 | 58 | 78 | ||||||
| Assets | 3,563 | 3,578 | 3,602 | 3,646 | 3,668 | 4,053 | 4,037 | 4,066 | 4,074 | 4,078 | 3,782 | 3,739 | ||||||
Liabilities Current | ||||||||||||||||||
| Secured Debt Current | 44 | 39 | 39 | 39 | 39 | 39 | 34 | 29 | 24 | 19 | 15 | 10 | ||||||
| Operating Lease Liability Current | 14 | 14 | 14 | 14 | 14 | 14 | 15 | 15 | 15 | 16 | 15 | 14 | ||||||
| Convertible Debt Current | - | - | 0 | 0 | 575 | 574 | 573 | 572 | - | - | 0 | - | ||||||
| Accounts Payable Trade Current | 83 | 88 | 96 | 92 | 93 | 91 | 83 | 78 | 107 | 94 | 92 | 94 | ||||||
| Contract With Customer Liability Current | 12 | 12 | 11 | 11 | 11 | 11 | 10 | 10 | 10 | 8 | 9 | 8 | ||||||
| Taxes Payable Current | 3 | 3 | 4 | - | - | - | 0 | - | - | - | - | - | ||||||
| Employee Related Liabilities Current | 68 | 58 | 74 | 75 | 67 | 52 | 86 | 76 | 70 | 53 | 75 | 64 | ||||||
| Accrued Liabilities Current | 108 | 133 | 130 | 133 | 131 | 137 | 122 | 132 | 102 | 112 | 101 | 90 | ||||||
| Liabilities Current | 331 | 347 | 456 | 364 | 930 | 918 | 922 | 913 | 328 | 302 | 307 | 356 | ||||||
| Convertible Debt Noncurrent | - | - | - | - | - | - | 0 | 0 | 572 | 571 | 570 | 570 | ||||||
| Secured Long Term Debt | 1,736 | 1,750 | 1,730 | 1,709 | 1,118 | 1,129 | 1,088 | 1,132 | 1,152 | 1,171 | 826 | 850 | ||||||
| Operating Lease Liability Noncurrent | 163 | 160 | 163 | 161 | 159 | 161 | 167 | 168 | 170 | 170 | 167 | 168 | ||||||
| Deferred Income Tax Liabilities Net | 3 | 6 | 6 | 58 | 60 | 58 | 61 | 69 | 87 | 31 | 35 | 74 | ||||||
| Other Liabilities Noncurrent | 194 | 196 | 204 | 233 | 253 | 160 | 146 | 190 | 155 | 140 | 200 | 142 | ||||||
| Liabilities | 2,520 | 2,535 | 2,559 | 2,609 | 2,629 | 2,529 | 2,492 | 2,544 | 2,540 | 2,480 | 2,194 | 2,160 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Additional Paid In Capital Common Stock | 1,346 | 1,341 | 1,338 | 1,334 | 1,328 | 1,323 | 1,323 | 1,317 | 1,302 | 1,311 | 1,302 | 1,262 | ||||||
| Treasury Stock Common Value | -687 | -687 | -689 | -690 | -690 | -690 | -691 | -692 | -681 | -646 | -647 | -613 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -40 | -31 | -30 | -32 | -31 | -24 | -28 | -25 | -19 | -11 | -15 | 2 | ||||||
| Retained Earnings Accumulated Deficit | 423 | 419 | 423 | 425 | 431 | 915 | 940 | 920 | 931 | 944 | 947 | 927 | ||||||
| Stockholders Equity | 1,043 | 1,042 | 1,043 | 1,038 | 1,039 | 1,524 | 1,545 | 1,522 | 1,534 | 1,598 | 1,588 | 1,579 | ||||||
| Liabilities And Stockholders Equity | 3,563 | 3,578 | 3,602 | 3,646 | 3,668 | 4,053 | 4,037 | 4,066 | 4,074 | 4,078 | 3,782 | 3,739 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 7 | 7 | 7 | 6 | 7 | 6 | 7 | 7 | 11 | 5 | 5 | 6 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 240 | 240 | 240 | 240 | 240 | 240 | 240 | 240 | 240 | 240 | 240 | 240 | ||||||
| Common Stock Shares Issued | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 91 | 91 | 91 | ||||||
| Treasury Stock Common Shares | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 13 | 13 | 12 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialINTEGRA LIFESCIENCES HOLDINGS CORP (IART) — SEC Financial Statements & Analysis
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) is a surgical & medical instruments & apparatus company, incorporated in DE. INTEGRA LIFESCIENCES HOLDINGS CORP trades on Nasdaq as: IART. INTEGRA LIFESCIENCES HOLDINGS CORP (IART)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29. Based on that filing, INTEGRA LIFESCIENCES HOLDINGS CORP carries a market cap of $1.39B, a P/E ratio of -191.66x, a P/B ratio of 1.33x, a P/S ratio of 0.84x, an enterprise value of $2.95B, and an EV/EBITDA multiple of 36.64x. On profitability, it posts a gross margin of 52.47%, an operating margin of 3.98%, a net margin of -0.44%, a Return on Equity (ROE) of -0.70%, a Return on Assets (ROA) of -0.20%, and a Return on Invested Capital (ROIC) of 2.51%. Per share, it reports EPS of $-0.09, diluted EPS of $-0.09, free cash flow per share of $0.33, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 1.60% year-over-year, net income growth of -98.55% year-over-year, and EPS growth of -98.56% year-over-year. On the balance sheet, it maintains a current ratio of 3.60x, a quick ratio of 1.80x, working capital of $860.60M, a debt-to-equity ratio of 2.42x, a debt ratio of 0.71, an interest coverage ratio of 0.71x, free cash flow of $25.80M (TTM), and net debt of $1.57B. Figures sourced from SEC EDGAR.
- Market Cap
- $1.39B
- P/E TTM
- -191.66x
- EPS TTM
- $-0.09
- P/B TTM
- 1.33x
- ROE TTM
- -0.70%
- ROA TTM
- -0.20%
- Debt To Equity
- 2.42x
- Free Cash Flow TTM
- $25.80M
- Net Revenue TTM Growth 1Y
- 1.60%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is INTEGRA LIFESCIENCES HOLDINGS CORP in?
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does IART trade on?
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) trades on the Nasdaq.
Where is INTEGRA LIFESCIENCES HOLDINGS CORP incorporated?
INTEGRA LIFESCIENCES HOLDINGS CORP is incorporated in DE.
When was INTEGRA LIFESCIENCES HOLDINGS CORP (IART)'s most recent SEC filing?
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29.
What is IART's market cap?
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) has a market capitalization of $1.39B as of 2026-06-30.
What is IART's EPS (earnings per share)?
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)'s trailing twelve month EPS is $-0.09 as of 2026-06-30.
What is IART's ROE (return on equity)?
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)'s trailing twelve month Return on Equity (ROE) is -0.70% as of 2026-06-30.
What is IART's ROA (return on assets)?
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)'s trailing twelve month Return on Assets (ROA) is -0.20% as of 2026-06-30.
What is IART's ROIC (return on invested capital)?
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)'s trailing twelve month Return on Invested Capital (ROIC) is 2.51% as of 2026-06-30.
What is IART's EV/EBITDA?
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)'s trailing twelve month EV/EBITDA is 36.64x as of 2026-06-30.